Avantor, Inc. — Cyborg Score 4/10

Mixed
Life Sciences Tools & Services

Strategic Profile

The company has launched its "Project Revival" initiative designed to sharpen strategic focus and improve execution across the organization, built around five pillars: evolving go-to-market strategy, improving operations, optimizing the portfolio, simplifying processes, and strengthening talent and accountability. Beginning in Q1 2026, Avantor is reorganizing into two new business units: a "product-agnostic channel" and a "channel-agnostic product business."

Cyborg Score Rationale

Avantor's $6.55 billion in trailing twelve-month sales was close to revenue five years ago, with revenue declining 3% annually over the last two years and organic revenue averaging 2.3% year-on-year declines. The company expects EBITDA margins to contract by 100-150 basis points in 2026, signaling near-term headwinds despite restructuring efforts.

Top Insights

  • Management characterized 2026 as a transitional year focused on strengthening the business while tracking improvement primarily through organic revenue growth.
  • Organic revenue growth is projected between -2.5% and -0.5% for 2026, suggesting continued top-line pressure.
  • Avantor planned $10 million to $15 million of investment in 2026 to upgrade VWR e-commerce platform customer interfaces.
  • Biopharma demand remained healthy, but early-stage biotech, education, and government segments faced headwinds, with improving funding environments in Europe and Japan but lingering uncertainty in the U.S.

Named Competitors

  • Thermo Fisher Scientific — Diversified life sciences tools and laboratory solutions
  • PerkinElmer — Laboratory equipment and scientific instruments
  • VWR Distribution — Rebranded distribution channel for lab supplies and chemicals
  • Azenta — Life sciences sample management solutions

Recent Developments

  • (February 2026) Q4 2025 earnings reported with 1.4% YoY revenue decline and launch of Revival turnaround program
  • (February 2026) Business reorganization into two segments: VWR Distribution & Services and Bioscience & Medtech Products
  • (Q4 2025) Relaunch of VWR brand for distribution channel and $20M operational improvement investment with new COO

Open the full interactive Avantor, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →